WOOJUNG BIO Inc - Asset Resilience Ratio

Latest as of September 2025: 0.27%

WOOJUNG BIO Inc (215380) has an Asset Resilience Ratio of 0.27% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 215380 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

₩240.00 Million

≈ $162.64K USD Cash + Short-term Investments

Total Assets

₩89.80 Billion

≈ $60.86 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how WOOJUNG BIO Inc's Asset Resilience Ratio has changed over time. See shareholders equity of WOOJUNG BIO Inc for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down WOOJUNG BIO Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see WOOJUNG BIO Inc (215380) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩240.00 Million	0.27%
Total Liquid Assets	₩240.00 Million	0.27%

Asset Resilience Insights

Limited Liquidity: WOOJUNG BIO Inc maintains only 0.27% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

WOOJUNG BIO Inc Industry Peers by Asset Resilience Ratio

Compare WOOJUNG BIO Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Royalty Pharma Plc NASDAQ:RPRX	Biotechnology	0.10%
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	3.28%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	4.52%
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	35.56%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	Biotechnology	4.35%

Annual Asset Resilience Ratio for WOOJUNG BIO Inc (2016–2024)

The table below shows the annual Asset Resilience Ratio data for WOOJUNG BIO Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.26%	₩248.30 Million ≈ $168.27K	₩94.70 Billion ≈ $64.18 Million	+0.11pp
2023-12-31	0.15%	₩150.00 Million ≈ $101.65K	₩98.33 Billion ≈ $66.64 Million	-4.92pp
2022-12-31	5.07%	₩4.82 Billion ≈ $3.27 Million	₩94.99 Billion ≈ $64.38 Million	-1.66pp
2021-12-31	6.74%	₩6.74 Billion ≈ $4.57 Million	₩100.14 Billion ≈ $67.86 Million	-15.88pp
2020-12-31	22.62%	₩15.79 Billion ≈ $10.70 Million	₩69.82 Billion ≈ $47.31 Million	-3.93pp
2019-12-31	26.55%	₩15.30 Billion ≈ $10.37 Million	₩57.63 Billion ≈ $39.06 Million	-12.30pp
2018-12-31	38.85%	₩17.41 Billion ≈ $11.80 Million	₩44.81 Billion ≈ $30.37 Million	+4.06pp
2017-12-31	34.80%	₩10.93 Billion ≈ $7.40 Million	₩31.40 Billion ≈ $21.28 Million	-64.24pp
2016-12-31	99.04%	₩11.88 Billion ≈ $8.05 Million	₩12.00 Billion ≈ $8.13 Million	--

pp = percentage points

About WOOJUNG BIO Inc

KQ:215380 Korea Biotechnology

Market Cap

$32.48 Million

₩47.93 Billion KRW

Market Cap Rank

#23456 Global

#1671 in Korea

Share Price

₩2875.00

Change (1 day)

-0.52%

52-Week Range

₩1427.00 - ₩3605.00

All Time High

₩13450.00